-
41
Design and Mechanical Simulation of CVT Mountain Bike
Published 2017-01-01Subjects: Get full text
Article -
42
-
43
-
44
Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants
Published 2025-12-01Subjects: Get full text
Article -
45
Technique for finding design solution for piston compressor with direct gas piston drive under conditions of depletion of the gas reservoir
Published 2019-12-01Subjects: “…booster compressor station…”
Get full text
Article -
46
-
47
Comparing Antibody Responses to Homologous vs. Heterologous COVID-19 Vaccination: A Cross-Sectional Analysis in an Urban Bangladeshi Population
Published 2025-01-01Subjects: Get full text
Article -
48
-
49
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Published 2024-12-01“…We have seen better results if the time interval between anti‐CD20 therapy and additional vaccine dose was longer than 6 months (5/8 patients achieved seroconversion on 4th booster dose after previous failure). Also, 36 patients received a 4th dose of vaccine as a booster with measurable increase in protective antibodies in 50% (18/36). …”
Get full text
Article -
50
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
Published 2025-03-01“…The administration of Omicron-adapted booster vaccines promoted a primary BA.2 RBD-specific B cell response, especially in participants who were immunocompromised. …”
Get full text
Article -
51
Recent developments in the therapeutics of SARS-CoV-2 infection
Published 2024-12-01Subjects: Get full text
Article -
52
-
53
Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: a randomized controlled study
Published 2025-12-01“…Background Due to high costs of pneumococcal conjugate vaccines (PCV), transitioning from a two (2 + 1) to a single dose (1 + 1) primary series with a booster should be considered. This study evaluated the immune response at 18 months of age following a 1 + 1 compared to a 2 + 1 schedule of 10-valent (PCV10) and 13-valent (PCV13) vaccines.Research design and methods A single-center, open-label, randomized trial conducted in Soweto, South Africa, evaluated the immunogenicity of differing dosing schedule for PCV10 and PCV13. …”
Get full text
Article -
54
Process equipment analysis integrated gas treatment unit for diethylene glycol absorbent change to triethylene glyco
Published 2020-06-01Subjects: “…booster compressor station…”
Get full text
Article -
55
Californie à Paris: Photographic Circulation and the Making of Imperial Identities, c. 1900
Published 2024-12-01Subjects: Get full text
Article -
56
-
57
-
58
The concept of reducing the man-made impact of launches of the promising Irtysh launch vehicle in the impact areas of the Baikonur cosmodrome
Published 2019-06-01“…The basic directions for reducing the anthropogenic impact of the spent booster of the first stage of the «Irtysh» type LV in the areas of falling are: determination of optimal areas for the spent booster to fall in selected areas of the FA with the highest stability and minimum cost of works on restoring the soil state — (A); controlled descent of the spent booster after separation from the LV to the designated section of the fall with an accuracy not exceeding the size of the selected optimal section — (B). …”
Get full text
Article -
59
Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vacci...
Published 2023-04-01“…In light of such situation, the vaccination against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is in desperate need of the third booster. It has been reported that heterologous boosters might produce more effective immunity against wild‐type SARS‐CoV‐2 and the variants. …”
Get full text
Article -
60
Solutions without Space-Time Separation for ADS Experiments: Overview on Developments and Applications
Published 2012-01-01“…The SC3A experiment in the YALINA-Booster facility is described and investigated. For this investigation the very special configuration of YALINA-Booster is analyzed based on HELIOS calculations. …”
Get full text
Article